Max Healthcare Institute Share News - Latest Updates, Live News & More

Latest news about Max Healthcare Institute

Max Healthcare Institute Sees ₹129.13 Crore Block Trade on NSE Oct 01, 2025

Max Healthcare Institute Ltd. experienced a significant block trade on the National Stock Exchange (NSE), involving 1,158,151 shares valued at ₹129.13 crore. The transaction was executed at ₹1,115.00 per share. Block trades often indicate institutional activity or major shareholder movements, potentially offering insights into investor sentiment and ownership changes.

Max Healthcare Institute Sees Rs. 131.16 Crore Block Trade on NSE Sep 25, 2025

Max Healthcare Institute Sees Rs. 119.33 Crore Block Trade on NSE Sep 23, 2025

GIC Private Limited Trims Stake in Max Healthcare to 5.813% Sep 22, 2025

Max Healthcare Institute Executes Rs. 15.96 Crore Block Trade on NSE Sep 10, 2025

More news about Max Healthcare Institute

14Aug 25

Max Healthcare Institute Sees Block Trade Worth Rs. 101.05 Crores on NSE

A significant block trade of 827,282 shares of Max Healthcare Institute Ltd. occurred on the National Stock Exchange (NSE), valued at Rs. 101.05 crores. The shares were traded at Rs. 1,221.50 per share. This transaction highlights ongoing interest in the healthcare sector and Max Healthcare Institute specifically. The identities of the parties involved in the trade were not disclosed.

14Aug 25

Max Healthcare Reports 27% Revenue Growth in Q1, Driven by Strong Patient Volumes

Max Healthcare Institute Limited reported robust Q1 financial results. Gross revenue increased 27% year-on-year to ₹2,574.00 crore, driven by a 26% rise in occupied bed days. Operating EBITDA grew 23% to ₹613.00 crore, with a 24.9% margin. Profit after tax rose 17% to ₹345.00 crore. The company saw improvements in bed occupancy, outpatient consultations, and international patient revenue. Max Healthcare continues its expansion with new hospital projects and strategic initiatives in non-hospital businesses.

13Aug 25

Max Healthcare Expands with New Hospital in Dehradun, Reports Strong Q1 Performance

Max Healthcare Institute plans to set up a new 130-bed hospital in Dehradun, focusing on advanced oncology services. The company reported robust Q1 financial results with revenue growing 31.4% YoY to ₹2,027.57 crore, EBITDA increasing 35.1% to ₹523.00 crore, and net profit rising 30.3% to ₹307.97 crore. Other developments include progress on subsidiary mergers, land acquisition for hospital expansion in Ghaziabad, divestment of hospitals in Bulandshahr, and allotment of shares under ESOP.

07Aug 25

Max Healthcare Institute Sees Rs. 50.66 Crore Block Trade on NSE

Max Healthcare Institute witnessed a significant block trade on NSE, with 403,231 shares changing hands at Rs. 1256.30 per share, totaling Rs. 50.66 crores. The company has scheduled its Q1 financial results announcement for August 13, followed by an earnings call on August 14 at 12:30 PM IST. Max Healthcare operates 22 healthcare facilities with over 5,100 beds, primarily in North India.

16Jul 25

Max Healthcare Engages in Discussions on Nationwide Unified Treatment Rates

Max Healthcare Institute Ltd is reportedly participating in discussions about implementing unified treatment rates across India. This initiative could lead to standardized healthcare costs nationwide, potentially improving transparency and accessibility in the healthcare sector. The move may face challenges in addressing regional cost variations and maintaining service quality. The outcome could significantly impact the healthcare industry's competitive landscape and pricing strategies.

12Jul 25

Max Healthcare Completes Sale of Stake in Sandhya Hydro Power Project

Max Healthcare Institute has completed the sale of 12,84,396 equity shares in the Sandhya Hydro Power Project to Skyzen Infrabuild Private Limited. The transaction occurred on July 11, 2025, following the termination of a power purchase agreement and board approval on May 20, 2025. This move aligns with Max Healthcare's strategy to focus on its core healthcare business.

30May 25

Max Healthcare Institute Shares: Major Block Trade Worth ₹55.26 Crore on NSE

A substantial block trade of 485,998 shares of Max Healthcare Institute Ltd. occurred on the National Stock Exchange (NSE) at a price of ₹1,137.00 per share, totaling ₹55.26 crore. This significant transaction suggests a notable shift in ownership for the company, which is a prominent player in India's healthcare sector. The identities of the buyer and seller were not disclosed.

22May 25

Max Healthcare Institute Unveils Ambitious Expansion Plan to Boost Capacity by 30%

Max Healthcare Institute has announced a significant expansion plan to increase its bed capacity from 6,500 to 9,000 by 2028. The company aims to add 1,500 beds in FY26, representing a 30% increase. A capex budget of Rs 5,000 crore has been allocated for FY26-FY28 to support this growth, primarily through brownfield projects. While focusing on organic growth, Max Healthcare remains open to acquisitions and expects continued revenue growth per bed.

20May 25

Max Healthcare Institute: Q4 Profit Surges 21%, Dividend Announced

Max Healthcare Institute has reported strong Q4 results with a 21% increase in profit after tax to ₹376.00 crore and a 29% growth in network gross revenue to ₹2,429.00 crore. The company announced a final dividend of ₹1.50 per share. Strategic expansion plans include land acquisition for hospital expansion and upcoming operations in three new brownfield towers.

15May 25

Max Healthcare Institute Shares See Significant Block Trade on NSE

A significant block trade of 449,617 shares of Max Healthcare Institute Ltd. was executed on the National Stock Exchange at ₹1,197.00 per share, totaling ₹53.82 crore. This large transaction suggests potential institutional activity or strategic moves by major investors, and could impact market sentiment, ownership structure, and demonstrate stock liquidity.

07May 25

Max Healthcare Refutes Reports of Bidding for Sahyadri Hospital

Max Healthcare Institute Ltd. (MHIL) has officially denied involvement in any bidding process for the acquisition of Sahyadri Hospital, countering recent media reports. The company issued a clarification to address speculation and ensure accurate information is available to stakeholders and the public.

06May 25

Max Healthcare Refutes Reports of Bidding for Sahyadri Hospital

Max Healthcare Institute Ltd (MHIL) has issued a clarification denying recent media reports about its alleged involvement in the acquisition of Sahyadri Hospital. The company explicitly stated that it is not participating in any bidding process for the acquisition, aiming to dispel rumors and provide transparency to stakeholders.

06May 25

Max Healthcare Institute Sees Significant Block Trade on NSE

A block trade of 207,749 shares of Max Healthcare Institute Ltd. was executed on the NSE at Rs. 1,165.80 per share, totaling Rs. 24.22 crores. This transaction indicates potential institutional investor activity or changes in major shareholdings, though the identities of the buyer and seller remain undisclosed.

29Apr 25

Max Healthcare Institute Unveils Ambitious Rs 6,000 Crore Expansion Plan

Max Healthcare Institute has announced plans to invest Rs 6,000 crore by 2028 to add 3,700 new beds across India. The expansion will increase their network from 22 to approximately 30 hospitals, with new facilities in Dwarka, Mohali, Mumbai, and Saket. The investment will be entirely funded through internal profit reinvestment, showcasing the company's strong financial position. This expansion is expected to increase healthcare accessibility, create jobs, and enhance India's overall healthcare infrastructure.

25Apr 25

Max Healthcare Institute Sees Major Block Trade Worth ₹109.19 Crore on NSE

Max Healthcare Institute Ltd. experienced a significant block trade on the National Stock Exchange, involving 1,002,923 shares valued at ₹109.19 crore. The transaction was executed at ₹1,088.70 per share. While the identities of the buyer and seller remain undisclosed, this large trade may indicate shifts in institutional holdings or strategic moves by major shareholders.

22Apr 25

Max Healthcare Institute Sees Significant Block Trade on NSE

A significant block trade of 187,046 shares of Max Healthcare Institute Ltd. was executed on the National Stock Exchange (NSE). The transaction was valued at Rs. 20.78 crore, with each share priced at Rs. 1,111.20. This large-scale trade, typically associated with institutional investors or major stakeholders, has drawn market attention due to its potential impact on stock price and trading volume.

25Mar 25

Max Healthcare Institute Sees ₹23.56 Crore Block Trade on NSE

A significant block trade of 203,079 shares of Max Healthcare Institute Ltd. occurred on the National Stock Exchange at ₹1,160.00 per share, totaling ₹23.56 crore. The transaction, typical of institutional investors or large stakeholders, was executed off the main trading floor to minimize market impact.

17Mar 25

Max Healthcare Institute Withdraws Petition Against Competition Commission of India

Max Healthcare Institute Ltd. (MHIL) has withdrawn its writ petition against the Competition Commission of India (CCI), which was previously filed to challenge a CCI order. This decision suggests a potential shift in the company's approach to addressing regulatory matters. The withdrawal could indicate a resolution, a strategic shift, or a move towards regulatory compliance. The implications of this action on Max Healthcare's operations and its relationship with the CCI remain to be seen.

14Mar 25

Max Healthcare Institute Withdraws Petition Against CCI, Signaling Shift in Legal Strategy

Max Healthcare Institute Limited has withdrawn its writ petition challenging a Competition Commission of India (CCI) order. The petition, filed in the Delhi High Court on March 12, 2025, contested CCI's rejection of applications for setting up a Confidentiality Ring and access to certain documents. The company retains the right to challenge CCI's reports through other legal means. This withdrawal, confirmed on March 13, 2025, marks a significant shift in Max Healthcare's legal strategy regarding its ongoing proceedings with the CCI.

12Mar 25

Max Healthcare to Expand Footprint with New 200-Bed Hospital in Delhi

Max Healthcare Institute Limited is partnering with Bharat Prakritik Chikitsa Mission to construct a 200-bed hospital in Pitampura, Delhi. The project, announced on March 12, 2025, is expected to be completed within 3-4 years. Max Healthcare will provide an interest-free, refundable deposit to BPCM, linked to construction milestones. The board of directors approved the Long-term Service Agreement during a meeting on the announcement date.

27Feb 25

Max Healthcare Institute Sees Significant Block Trade Worth Rs. 18.92 Crores on NSE

A significant block trade of 187,032 shares of Max Healthcare Institute Ltd. occurred on the National Stock Exchange (NSE) at Rs. 1,011.65 per share, totaling Rs. 18.92 crores. The transaction, while substantial, doesn't necessarily indicate changes in company fundamentals. Investors are advised to monitor potential impacts on stock performance and consider multiple factors in their decision-making.

27Feb 25

Max Healthcare Institute Ltd. Sees Significant Block Trade Amidst Corporate Restructuring

Max Healthcare Institute Ltd. experienced a significant block trade of 507,542 shares valued at Rs. 51.64 crores on the NSE. Concurrently, the company is undergoing a corporate restructuring, with NCLT Mumbai approving the merger of two wholly-owned subsidiaries, ALPS Hospital Limited and Max Hospitals and Allied Services Limited, effective April 1, 2024. The merger aims to enhance financial strength, operational synergies, and simplify the corporate structure.

27Feb 25

Max Healthcare Institute Ltd. Sees Significant Block Trade Amidst Corporate Restructuring

Max Healthcare Institute Ltd. experienced a significant block trade of 203,634 shares at Rs. 1,034.50 per share on the NSE, totaling Rs. 21.07 crores. Concurrently, the company received NCLT approval for the amalgamation of its subsidiaries, ALPS Hospital Limited and Max Hospitals and Allied Services Limited, effective April 1, 2024. This restructuring aims to strengthen operations, enhance expansion capacity, and improve financial efficiency.

27Feb 25

Max Healthcare Subsidiaries Merger Approved by NCLT

Max Healthcare Institute Limited's wholly-owned subsidiaries, Alps Hospital Limited and Max Hospitals and Allied Services Limited, received NCLT approval for amalgamation on February 25, 2025, effective from April 1, 2024. The merger aims to enhance operational scale, financial strength, and efficiency within the group. Benefits include improved resource utilization, cost efficiencies, simplified structure, and better governance. No change in Max Healthcare's shareholding pattern is expected.

26Feb 25

Max Healthcare Subsidiaries Merger Approved: NCLT Gives Green Light to Alps Hospital and Max Hospitals Amalgamation

Max Healthcare Institute Limited announced NCLT approval for the merger of its wholly-owned subsidiaries, Alps Hospital Limited and Max Hospitals and Allied Services Limited. The amalgamation, effective from April 1, 2024, aims to streamline operations, enhance scale, create operational synergies, improve growth capacity, and simplify the corporate structure. The move is expected to optimize resource utilization, reduce operational complexities, and potentially improve financial performance and market position.

20Feb 25

Max Healthcare Institute Sees Rs. 21.39 Crore Block Trade on NSE

A significant block trade of 207,706 shares of Max Healthcare Institute Ltd. occurred on the National Stock Exchange (NSE) at Rs. 1,029.95 per share, totaling Rs. 21.39 crores. While the identities of the parties involved remain undisclosed, the transaction's size suggests institutional or high net-worth individual involvement. This trade has drawn market attention, although it doesn't necessarily indicate changes in company fundamentals or overall market sentiment.